Research & Literature

Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens.

Andries AC, Duong V, Ly S, et al.

PLoS neglected tropical diseases 2015; (9(9)):e0004100 doi:10.1371/journal.pntd.0004100.

The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.

Pitisuttithum P, Bouckenooghe A

Expert review of vaccines 2016; (15(7)):795-8 doi:10.1080/14760584.2016.1189331.

Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability.

Puerta-Guardo H, Glasner DR, Harris E

PLoS pathogens 2016; (12(7)):e1005738 doi:10.1371/journal.ppat.1005738.

Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.

Her Z, Kam YW, Gan VC, et al.

The Journal of infectious diseases 2017; (215(1)):42-51 doi:10.1093/infdis/jiw494.

Immune-mediated cytokine storm and its role in severe dengue.

Srikiatkhachorn A, Mathew A, Rothman AL

Seminars in immunopathology 2017; (39(5)):563-574 doi:10.1007/s00281-017-0625-1.

Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement.

de Almeida RR, Paim B, de Oliveira SA, et al.

Lung 2017; (195(4)):389-395 doi:10.1007/s00408-017-0021-6.

Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.

Glasner DR, Ratnasiri K, Puerta-Guardo H, et al.

PLoS pathogens 2017; (13(11)):e1006673 doi:10.1371/journal.ppat.1006673.

Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV.

Wilder-Smith A

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; (24(7)):680-681 doi:10.1016/j.cmi.2018.03.024.

Prolonged persistence of IgM against dengue virus detected by commonly used commercial assays.

Chien YW, Liu ZH, Tseng FC, et al.

BMC infectious diseases 2018; (18(1)):156 doi:10.1186/s12879-018-3058-0.

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.

Sridhar S, Luedtke A, Langevin E, et al.

The New England journal of medicine 2018; (379(4)):327-340 doi:10.1056/NEJMoa1800820.

A simple mathematical model to describe antibody-dependent enhancement in heterologous secondary infection in dengue.

Cerón Gómez M, Yang HM

Mathematical medicine and biology : a journal of the IMA 2019; (36(4)):411-438 doi:10.1093/imammb/dqy016.

Risk of Dengue in Travelers: Implications for Dengue Vaccination.

Wilder-Smith A

Current infectious disease reports 2018; (20(12)):50 doi:10.1007/s11908-018-0656-3.

Support for vector control strategies in the United States during the Zika outbreak in 2016: The role of risk perception, knowledge, and confidence in government.

Piltch-Loeb R, Merdjanoff AA, Bhanja A, Abramson DM

Preventive medicine 2019; (119()):52-57 doi:10.1016/j.ypmed.2018.12.019.

The analysis of clinical and laboratory data: a large outbreak of dengue fever in Chaozhou, Guangdong province, China.

Lin F, Yang H, Zhang L, et al.

Archives of virology 2019; (164(8)):2131-2135 doi:10.1007/s00705-019-04266-1.

The Mosquito Immune System and the Life of Dengue Virus: What We Know and Do Not Know.

Mukherjee D, Das S, Begum F, et al.

Pathogens (Basel, Switzerland) 2019; (8(2)) doi:10.3390/pathogens8020077.

Recent advances in understanding dengue.

Halstead S

F1000Research 2019; (8()) doi:10.12688/f1000research.19197.1.

Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.

Chan CYY, Low JZH, Gan ES, et al.

mSphere 2019; (4(5)) doi:10.1128/mSphere.00528-19.

The importance of vector control for the control and elimination of vector-borne diseases.

Wilson AL, Courtenay O, Kelly-Hope LA, et al.

PLoS neglected tropical diseases 2020; (14(1)):e0007831 doi:10.1371/journal.pntd.0007831.

Dengue virus non-structural protein 1 activates the p38 MAPK pathway to decrease barrier integrity in primary human endothelial cells.

Barbachano-Guerrero A, Endy TP, King CA

The Journal of general virology 2020; (101(5)):484-496 doi:10.1099/jgv.0.001401.

Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.

Wang WH, Urbina AN, Chang MR, et al.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2020; (53(6)):963-978 doi:10.1016/j.jmii.2020.03.007.

Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.

Rathore APS, Senanayake M, Athapathu AS, et al.

Scientific reports 2020; (10(1)):11856 doi:10.1038/s41598-020-68844-z.

The role of IgG Fc receptors in antibody-dependent enhancement.

Bournazos S, Gupta A, Ravetch JV

Nature reviews. Immunology 2020; (20(10)):633-643 doi:10.1038/s41577-020-00410-0.

A Case Report on Dengue Encephalitis With Optic Neuropathy.

Khan N, Bhatti JM

Cureus 2020; (12(8)):e9592 doi:10.7759/cureus.9592.

Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.

Durbin AP

Current opinion in virology 2020; (43()):79-87 doi:10.1016/j.coviro.2020.09.005.

Gall Bladder Wall Thickening in Dengue Fever - Aid in Labelling Dengue Hemorrhagic Fever and a Marker of Severity.

Adil B, Rabbani A, Ahmed S, et al.

Cureus 2020; (12(11)):e11331 doi:10.7759/cureus.11331.

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.

López-Medina E, Biswal S, Saez-Llorens X, et al.

The Journal of infectious diseases 2022; (225(9)):1521-1532 doi:10.1093/infdis/jiaa761.

Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis.

Sangkaew S, Ming D, Boonyasiri A, et al.

The Lancet. Infectious diseases 2021; (21(7)):1014-1026 doi:10.1016/S1473-3099(20)30601-0.

An unusual case of acute motor axonal neuropathy (AMAN) complicating dengue fever.

Kumar SS, Baitha U, Vyas S

Drug discoveries & therapeutics 2021; (15(4)):214-217 doi:10.5582/ddt.2021.01063.

Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis.

Thach TQ, Eisa HG, Hmeda AB, et al.

PLoS neglected tropical diseases 2021; (15(10)):e0009808 doi:10.1371/journal.pntd.0009808.

Clinical predictors of severe dengue: a systematic review and meta-analysis.

Tsheten T, Clements ACA, Gray DJ, et al.

Infectious diseases of poverty 2021; (10(1)):123 doi:10.1186/s40249-021-00908-2.

Altered Moesin and Actin Cytoskeleton Protein Rearrangements Affect Transendothelial Permeability in Human Endothelial Cells upon Dengue Virus Infection and TNF-α Treatment.

Suttitheptumrong A, Mahutchariyakul T, Rawarak N, et al.

Viruses 2021; (13(10)) doi:10.3390/v13102042.

Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes.

Abraham PR, R B, N PK, Kumar A

Scientific reports 2021; (11(1)):23699 doi:10.1038/s41598-021-02965-x.

Dengue hemorrhagic fever and the liver.

Leowattana W, Leowattana T

World journal of hepatology 2021; (13(12)):1968-1976 doi:10.4254/wjh.v13.i12.1968.

Dynamic Changes of Platelet and Factors Related Dengue Haemorrhagic Fever: A Retrospective Study in Indonesian.

Faridah IN, Dania H, Chen YH, et al.

Diagnostics (Basel, Switzerland) 2022; (12(4)) doi:10.3390/diagnostics12040950.

A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update.

Almas MF, Toussi M, Valero E, et al.

Pharmacoepidemiology and drug safety 2022; (31(7)):758-768 doi:10.1002/pds.5447.

Fulminant Hepatic Failure in Dengue Fever Without Plasma Leakage: A Case Report.

Arunpriyandan V, Sundaresan KT

Cureus 2022; (14(4)):e23964 doi:10.7759/cureus.23964.

Clinicopathological alteration of symptoms with serotype among dengue infected pediatric patients.

Verma P, Banerjee S, Baskey U, et al.

Journal of medical virology 2022; (94(9)):4348-4358 doi:10.1002/jmv.27862.

Association of dengue virus non-structural-1 protein with disease severity: a brief review.

Ghetia C, Bhatt P, Mukhopadhyay C

Transactions of the Royal Society of Tropical Medicine and Hygiene 2022; (116(11)):986-995 doi:10.1093/trstmh/trac087.

Coagulopathy of Dengue and COVID-19: Clinical Considerations.

Islam A, Cockcroft C, Elshazly S, et al.

Tropical medicine and infectious disease 2022; (7(9)) doi:10.3390/tropicalmed7090210.

Factors associated with deaths from dengue in a city in a metropolitan region in Southeastern Brazil: a case-control study.

Sousa SC, Silva TAMD, Soares AN, et al.

Revista da Sociedade Brasileira de Medicina Tropical 2022; (55()):e0043 doi:10.1590/0037-8682-0043-2022.

Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach.

Zeyaullah M, Muzammil K, AlShahrani AM, et al.

Vaccines 2022; (10(11)) doi:10.3390/vaccines10111940.

Epidemiological Investigation of the 2019 Dengue Outbreak in Dhaka, Bangladesh.

Yesmin S, Sarmin S, Ahammad AM, et al.

Journal of tropical medicine 2023; (2023()):8898453 doi:10.1155/2023/8898453.

Performance of VIDAS® Diagnostic Tests for the Automated Detection of Dengue Virus NS1 Antigen and of Anti-Dengue Virus IgM and IgG Antibodies: A Multicentre, International Study.

Versiani AF, Kaboré A, Brossault L, et al.

Diagnostics (Basel, Switzerland) 2023; (13(6)) doi:10.3390/diagnostics13061137.

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?

Teo A, Tan HD, Loy T, et al.

PLoS pathogens 2023; (19(3)):e1011223 doi:10.1371/journal.ppat.1011223.

Grape Seed Proanthocyanidins Inhibit Replication of the Dengue Virus by Targeting NF-kB and MAPK-Mediated Cyclooxygenase-2 Expression.

Chen WC, Hossen M, Liu W, et al.

Viruses 2023; (15(4)) doi:10.3390/v15040884.

The effect of temperature on dengue virus transmission by Aedes mosquitoes.

Liu Z, Zhang Q, Li L, et al.

Frontiers in cellular and infection microbiology 2023; (13()):1242173 doi:10.3389/fcimb.2023.1242173.

Dengue hemorrhagic fever: a growing global menace.

Parveen S, Riaz Z, Saeed S, et al.

Journal of water and health 2023; (21(11)):1632-1650 doi:10.2166/wh.2023.114.

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

Tricou V, Yu D, Reynales H, et al.

The Lancet. Global health 2024; (12(2)):e257-e270 doi:10.1016/S2214-109X(23)00522-3.

Severe dengue in the intensive care unit.

Tejo AM, Hamasaki DT, Menezes LM, Ho YL

Journal of intensive medicine 2024; (4(1)):16-33 doi:10.1016/j.jointm.2023.07.007.

Evolving Spectrum of Dengue: A Two-Year Experience From a Tertiary Care Hospital in Pakistan.

Syed F, Arif MA, Mansoor VB, et al.

Cureus 2024; (16(2)):e53817 doi:10.7759/cureus.53817.

Factors associated with mosquito control among construction workers: A systematic review.

Dapari R, Mohd Fadzil MF, Hanzir MY, et al.

PloS one 2024; (19(5)):e0303330 doi:10.1371/journal.pone.0303330.

Airway breathing circulation dengue: a case of multifactorial shock due to major trauma and severe dengue infection.

Hoang BH, Tang TV, Phan NDN, et al.

International journal of emergency medicine 2024; (17(1)):90 doi:10.1186/s12245-024-00673-7.

Effectiveness of Wolbachia-mediated sterility coupled with sterile insect technique to suppress adult Aedes aegypti populations in Singapore: a synthetic control study.

Bansal S, Lim JT, Chong CS, et al.

The Lancet. Planetary health 2024; (8(9)):e617-e628 doi:10.1016/S2542-5196(24)00169-4.

Reply to: Editorial "The increasing use of T-cell stimulation for successful dengue vaccination" in eBioMedicine 2024; 102, 105120. DOI: https://doi.org/10.1016/j.ebiom.2024.105120.

Kandeil W, Nascimento E, Tricou V, et al.

EBioMedicine 2024; (108()):105370 doi:10.1016/j.ebiom.2024.105370.

Long term T cell response and safety of a tetravalent dengue vaccine in healthy children.

Mandaric S, Friberg H, Saez-Llorens X, et al.

NPJ vaccines 2024; (9(1)):192 doi:10.1038/s41541-024-00967-0.

Dengue virus NS1 hits hard at the barrier integrity of human cerebral microvascular endothelial cells via cellular microRNA dysregulations.

Apoorva , Kumar A, Singh SK

Tissue barriers 2025; (13(3)):2424628 doi:10.1080/21688370.2024.2424628.

Clinical Performance of MAGLUMI Diagnostic Tests for the Automated Detection of Dengue Virus.

Peng B, Fang Z, Li C, et al.

Viruses 2025; (17(1)) doi:10.3390/v17010106.

Fever and Rash in a Traveler.

Reddy M, Curtin J

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025; (80(1)):215-218 doi:10.1093/cid/ciae376.

Diagnosis and Management of Dengue Fever in a Nonendemic Country: Lessons From an Acute Febrile Illness in Iran During the COVID-19 Outbreak.

Mozahheb Yousefi K, Aminian S, Ebrahimi M, et al.

Case reports in infectious diseases 2025; (2025()):5742576 doi:10.1155/crdi/5742576.

Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review.

Naderian R, Eslami M, Ahmad S, et al.

Reviews in medical virology 2025; (35(3)):e70035 doi:10.1002/rmv.70035.

Key Laboratory Markers for Early Detection of Severe Dengue.

Sivasubramanian K, Bharath R R, Vajravelu LK, et al.

Viruses 2025; (17(5)) doi:10.3390/v17050661.

Vertical transmission of Dengue virus type-3 and metagenomic virome profiles of Aedes aegypti mosquitoes collected in Kisumu, Kenya.

Wanjiru T, Bulimo W, Langat S, et al.

PloS one 2025; (20(7)):e0315492 doi:10.1371/journal.pone.0315492.

Clinico-epidemiological determinants of severe dengue in an endemic district of coastal Karnataka.

Nivetha S, Kumar A, Eshwari K, et al.

Infectious diseases (London, England) 2025; (57(11)):1068-1077 doi:10.1080/23744235.2025.2528132.

Mammalian-targeted antiviral peptide reduces dengue virus type 1 infection in Aedes aegypti.

Medina-Carrasco D, Santiago GC, Garay Pérez HE, et al.

Antiviral research 2025; (241()):106241 doi:10.1016/j.antiviral.2025.106241.

Host factors and genetic polymorphisms influencing dengue infection.

Mehak MA, Khan M, Razu MH

Virus research 2025; (360()):199623 doi:10.1016/j.virusres.2025.199623.

Bioactivity of Linalool Against Culex quinquefasciatus: Repellent and Larvicidal Evaluations.

Kumar R, Mittal P, Airi M

Archives of insect biochemistry and physiology 2025; (120(1)):e70098 doi:10.1002/arch.70098.

Pathophysiology and clinical implications of dengue-associated neurological disorders.

Naderian R, Paraandavaji E, Maddah AH, et al.

Frontiers in microbiology 2025; (16()):1536955 doi:10.3389/fmicb.2025.1536955.

Evaluation of the efficacy of 20% IR3535® with a sustained-release formulation and 25% DEET insect repellents against mosquitoes in a field setting in Ghana.

Abudu M, Asafu-Adjaye A, Osei JHN, et al.

Parasites & vectors 2025; (18(1)):398 doi:10.1186/s13071-025-06946-1.

Engineered Nanobodies for early and accurate diagnosis of dengue virus infection.

Pavan MF, Malnero CM, Mora Alvarado ME, et al.

PLoS neglected tropical diseases 2025; (19(10)):e0013168 doi:10.1371/journal.pntd.0013168.

Dengue Fever Diagnosis: Performance Characteristics of Current Tests and Emerging Detection Technologies.

Ewaisha R, Saady M, Khalifa L, Azzazy HME

Molecular diagnosis & therapy 2025; doi:10.1007/s40291-025-00822-5.

Dengue Infection in Pediatric Patients With Malignancies: A Single-center Retrospective Study.

Rajan Radha R, Rajeswari B, Varikkattu Rajendran P, et al.

Journal of pediatric hematology/oncology 2026; (48(1)):e11-e14 doi:10.1097/MPH.0000000000003156.

Dengue virus modulates the fibrinolytic system to drive vascular leakage and serves as a therapeutic target for tranexamic acid.

Wang WH, Lin CY, Huang S, et al.

European journal of pharmacology 2026; (1015()):178553 doi:10.1016/j.ejphar.2026.178553.

Post-marketing safety profile of dengue vaccines CYD-TDV and TAK-003: analysis of adverse event reports from a European database.

Gianguzzo VM, Rottura M, Sacco FM, et al.

Frontiers in pharmacology 2026; (17()):1789762 doi:10.3389/fphar.2026.1789762.